← brief for 2026-10-20 · Slowing decline

Longitudinal kidney outcomes and safety after finerenone initiation in patients with non-diabetic chronic kidney disease: a single-center retrospective cohort study

Article C Peer reviewed Observational

Key takeaways

This study followed people with kidney disease who started a drug called finerenone. It looked at how their urine protein levels changed over time. This shows a link in real-world care, but it is not a controlled trial.

Who did this work

Xuejuan Sun (Fujian Medical University) · Juan Pei (Fujian Medical University) · Xing Chen (Fujian Medical University) · Zhi Wang (Fujian Medical University) · Lijing Yao (Fujian Medical University) · Peijin Bai (Fujian Medical University) · Zhiwen Yan (Fujian Medical University) · Yinan Li (Fujian Medical University) · Leping Shao (Fujian Medical University)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-19
https://doi.org/10.3389/fmed.2026.1959259